Memorial Sloan Kettering invests in oncology startup Cota's Series C funding round

Cota completed its Series C investment round with $40 million in funding, the New York City-based healthcare analytics startup confirmed Feb. 21.

IQVIA, a Durham, N.C.-based healthcare technology and contract research services provider, led the funding round with major participation by EW Healthcare Partners, a New York City-based pharmaceutical company focused on oncology.

New York City-based Memorial Sloan Kettering Cancer Center also participated in the funding round, along with a group of existing investors. Memorial Sloan Kettering entered into a multiyear partnership with Cota in November, under which the cancer center will provide the startup with anonymized clinical data.

Cota's leadership team plans to use the Series C funding to scale its solution across healthcare providers, payers and life sciences companies. Cota's solution helps healthcare organizations apply precision medicine by categorizing patient demographic factors, diseases and therapies.

More articles on data analytics & precision medicine:
Report: Annual VC investment in genomics companies rises 142% since 2016
Cedars-Sinai researchers investigate 'patient-on-a-chip' tech to drive precision medicine
Survey: More than 80% of payers integrate social determinants of health data into programs

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers